Helen Mossop
0000-0002-6260-3734
Newcastle University
22 papers found
Refreshing results…
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
Missing publications? Search for publications with a matching author name.